7. Department of Pathology

142:21-29. 20177) Ainai A, Suzuki T, Tamura SI, Hasegawa H. Intranasal

1) Willems L, Hasegawa H, Accolla R, Bangham C,

Administration of Whole Inactivated Influenza Virus

Bazarbachi A, Bertazzoni U, Carneiro-Proietti AB,

Vaccine as a Promising Influenza Vaccine Candidate.

Cheng

Viral Immunol. 30(6):451-462. 2017

H,

Chieco-Bianchi

L,

Ciminale

V,Coelho-Dos-Reis J, Esparza J, Gallo RC, Gessain A,

8) Fujimoto Y, Hasegawa S, Matsushige T, Wakiguchi H,Gotuzzo E, Hall W, Harford J, Hermine O, Jacobson S,Nakamura T, Hasegawa H, Nakajima N, Ainai A, Oga

Macchi B, Macpherson C, Mahieux R, Matsuoka M,A, Itoh H, Shirabe K, Toda S, Atsuta R, Morishima T,Murphy E, Peloponese JM, Simon V, Tagaya Y, Taylor

Ohga

GP, Watanabe T, Yamano Y. Reducing the global

dynamics of bronchoalveolar lavage fluid from a mouseburden of HTLV-1 infection: An agenda for researchmodel of bronchial asthma during A(H1N1)pdm09

and action. Antiviral Res. 137:41-48. 2017

influenza infection. Sci Rep. 7(1):9128. 20172) Iwatsuki-Horimoto

K,Nakajima

N,ShibataS.

Pulmonary

inflammation

andcytokine

M,9) Kiso M, Iwatsuki-Horimoto K, Yamayoshi S, Uraki R,Takahashi K, Sato Y, Kiso M, Yamayoshi S, Ito M,Ito M, Nakajima N, Yamada S, Imai M, Kawakami E,Enya S, Otake M, Kangawa A, da Silva Lopes TJ, Ito H,Tomita Y, Fukuyama S, Itoh Y, Ogasawara K, Lopes

Hasegawa H, Kawaoka Y. The Microminipig as an

TJS, Watanabe T, Moncla LH, Hasegawa H, Friedrich

Animal Model for Influenza A Virus Infection. J Virol.

TC,91(2). pii: e01716-16. 2017

Oseltamivir-Resistant3) Kaneko M, Maruta M, Shikata H, Asou K, Shinomiya H,Suzuki T, Hasegawa H, Shimojima M, Saijo M.

NeumannG,

Kawaoka
H7N9Y.

Emergence

Influenzaof

Viruses in

Immunosuppressed Cynomolgus Macaques. J Infect Dis.
216(5):582-593. 2017

Unusual presentation of a severely ill patient having

10) Suzuki T*, Ainai A, Hasegawa H. Functional andsevere fever with thrombocytopenia syndrome: a casestructural characteristics of secretory IgA antibodies

report. J Med Case Rep. 11(1):27. 2017

elicited by mucosal vaccines against influenza virus.

4) Kawaguchi A, Suzuki T*, Ohara Y, Takahashi K, SatoY, Ainai A, Nagata N, Tashiro M, Hasegawa H. Impacts

Vaccine.

35(39):5297-5302.

2017.

*Corresponding

authorof allergic airway inflammation on lung pathology in a11) Sano K, Ainai A, Suzuki T, Hasegawa H. The road to amouse model of influenza A virus infection. PLoS One.

more effective influenza vaccine: Up to date studies and12(2):e0173008. 2017. *Corresponding author

future prospects. Vaccine. 35(40):5388-5395. 20175) Hayashi K, Yoshida H, Sato Y, Tobiume M, Suzuki Y,Ariyoshi

K,Histopathological12) Okumura A, Saito T, Tobiume M, Hashimoto Y, Sato Y,Hasegawa

H,Nakajima

N.

Umeyama T, Nagi M, Tanabe K, Unoki-Kubota H,

FindingsofLung

with

Kaburagi Y, Hasegawa H, Miyazaki Y, Yamagoe S.

A/H1N1pdm09 Infection-Associated Acute Respiratory

Alleviation

Distress Syndrome in the Post-Pandemic Season. Jpn J

lipopolysaccharide/d-galactosamine-induced liver injury

Infect Dis. 70(2):197-200. 2017

in leukocyte cell-derived chemotaxin 2 deficient mice.

6) Akkina R, Ellerbrok H, Hall W, Hasegawa H,ofBiochem Biophys Rep. 12:166-171. 2017

Kawaguchi Y, Kleanthous H, McSweegan E, Mercer N,13) Imai M, Watanabe T, Kiso M, Nakajima N, Yamayoshi

Romanowski V, Sawa H, Vahlne A. 2016 International

S, Iwatsuki-Horimoto K, Hatta M, Yamada S, Ito M,

meeting of the Global Virus Network. Antiviral Res.

Sakai-Tagawa Y, Shirakura M, Takashita E, Fujisaki S,

McBride R, Thompson AJ, Takahashi K, Maemura T,lymphomas. Cancer Med. 6: 605-618. 2017

Mitake H, Chiba S, Zhong G, Fan S, Oishi K, Yasuhara20) Mine S, Hishima T, Suganuma A, Fukumoto H, Sato Y,A, Takada K, Nakao T, Fukuyama S, Yamashita M,Kataoka M, Sekizuka T, Kuroda M, Suzuki T,Lopes TJS, Neumann G, Odagiri T, Watanabe S, Shu Y,Hasegawa

Paulson JC, Hasegawa H, Kawaoka Y. A HighlyInterleukin-6-dependent growth in a newly establishedPathogenic Avian H7N9 Influenza Virus Isolated fromplasmablastic lymphoma cell line and its therapeutic

A Human Is Lethal in Some Ferrets Infected viatargets. Sci Rep. 7(1):10188. 2017

RespiratoryDroplets.

Cell

HostMicrobe.

22(5):615-626.e8. 2017

H,Fukayama

M,KatanoH.

21) Koyama K, Horiuchi N, Hasegawa H, Katano H,Oohashi E, Watanabe K, Kobayashi Y. Cytomegalic14) Moriyama M, Takeyama H, Hasegawa H, Ichinohe T.

Inclusion Disease caused by Cytomegalovirus Infection

Induction of lung CD8(+) T cell responses byin the Salivary Glands of an African Hedgehog

consecutive inoculations of a poly(I:C) influenza(Atelerix arbiventris). J Compar Pathol. 157: 299-302,vaccine.Vaccine. 35(48 Pt B):6620-6626. 2017201715) Takaki H, Takashima K, Oshiumi H, Ainai A, Suzuki T,Hasegawa H, Matsumoto M, Seya T. cGAMP Promotes

22) Itoh N, Katano H, Nakayama SI, Kurai H. GastricSyphilis. Intern Med. 56: 1753. 2017

Germinal Center Formation and Production of IgA in23) Goto H, Kariya R, Kudo E, Okuno Y, Ueda K, Katano

Nasal-Associated Lymphoid Tissue. Med Sci (Basel).

H, Okada S. Restoring PU.1 induces apoptosis and5(4). pii: E35. 2017

modulates viral transactivation via interferon-stimulated16) Terasaki F, Fukumoto H, Kawata R, Hirose Y, Fujita SI,Katano H, Ishizaka N. A comprehensive search forgenes in primary effusion lymphoma. Oncogene. 36:
5252-5262, 2017

microbial DNA and RNA in sarcoidosis tissue samples

24) Awazawa R, Utsumi D, Katano H, Awazawa T, Miyagiby quantitative polymerase chain reaction. Infect DisT, Hayashi K, Matori S, Uezato H, Takahashi K. High(Lond). 49: 625-627. 2017

PrevalenceofDistinct

HumanHerpesvirus817) Takahashi K, Sekizuka T, Fukumoto H, Nakamichi K,

Contributes to the High Incidence of Non-acquired

Suzuki T, Sato Y, Hasegawa H, Kuroda M, Katano H.

Immune Deficiency Syndrome-Associated Kaposi's

Deep-Sequence Identification and Role in Virus

Sarcoma in Isolated Japanese Islands. J Infect Dis. 216:

Replication of a JC Virus Quasispecies in Patients with850-858. 2017

Progressive Multifocal Leukoencephalopathy. J Virol.
91: e01335-16. 201725) Egawa K, Shimojima M, Taniguchi S, Nagata N, Tani H,Yoshikawa T, Kurosu T, Watanabe S, Fukushi S, Saijo

18) Sunagawa K, Hishima T, Fukumoto H, Hasegawa H,M. Virulence, pathology, and pathogenesis of Pteropine

Katano H. Conserved sequences of BART and BHRF

orthoreovirus (PRV) in BALB/c mice: Development ofregions encoding viral microRNAs in Epstein-Barran animal infection model for PRV. PLoS Negl Tropvirus-associated lymphoma. BMC Res Notes. 10: 279.

Dis. 11(12):e0006076. 2017201726) Sakata M, Tani H, Anraku M, Kataoka M, Nagata N,19) Sakamoto K, Sekizuka T, Uehara T, Hishima T, Mine S,Seki F, Tahara M, Otsuki N, Okamoto K, Takeda M,Fukumoto H, Sato Y, Hasegawa H, Kuroda M, Katano

Mori Y. Analysis of VSV pseudotype virus infection

H. Next-generation sequencing of miRNAs in clinicalmediated by rubella virus envelope proteins. Sci Rep.

samples7(1):11607. 2017ofEpstein-Barrvirus-associatedB-cell27) Taniguchi S, Maeda K, Horimoto T, Masangkay JS,Puentespina R Jr, Alvarez J, Eres E, Cosico E, Nagata N,Precursor Form with Reverse Transcriptase. J Virol. 91:e02003-16. 2017

Egawa K, Singh H, Fukuma A, Yoshikawa T, Tani H,33) Fukushi S, Fukuma A, Kurosu T, Watanabe S,Fukushi S, Tsuchiaka S, Omatsu T, Mizutani T, Une Y,Shimojima M, Shirato K, Iwata-Yoshikawa N, Nagata

Yoshikawa Y, Shimojima M, Saijo M, Kyuwa S. FirstN, Ohnishi K, Ato M, Melaku SK, Sentsui H, Saijo M.

isolation

Characterization of novel monoclonal antibodies against

andcharacterizationofpteropine

orthoreoviruses in fruit bats in the Philippines. ArchtheVirol. 162(6):1529-1539. 2017

application in species-independent antibody detection28) Iizuka I, Ami Y, Suzaki Y, Nagata N, Fukushi S, Ogata
M, Morikawa S, Hasegawa H, Mizuguchi M, Kurane I,

MERS-coronavirus

spike

proteinandtheirby competitive ELISA. J Virol Methods. 251:22-29.
2017

Saijo M. A Single Vaccination of Nonhuman Primates

34) Li TC, Yoshizaki S, Kataoka M, Ami Y, Suzaki Y,with Highly Attenuated Smallpox Vaccine, LC16m8,

Doan YH, Haga K, Ishii K, Takeda N, Wakita T.

Provides Long-term Protection against Monkeypox. Jpn

Genetic and physicochemical analyses of a novel ferret

J Infect Dis. 70(4):408-415. 2017

hepatitis E virus, and clinical signs of infection after29) Phung TTB, Suzuki T, Phan PH, Kawachi S, Furuya H,birth. Infect Genet Evol. 51:153-159. 2017

Do HT, Kageyama T, Ta TA, Dao NH, Nunoi H, Tran35) Ogawa M, Satoh M, Kataoka M, Ando S, Saijo M.

DM, Le HT, Nakajima N. Pathogen screening andNitric oxide enhanced the growth of an obligatedprognostic factors in children with severe ARDS of

intracellularpulmonary origin. Pediatr Pulmonol. 52(11):1469-1477.

murine macrophages. Microb Pathog. 107:335-340.

2017

2017

bacteriumOrientia

tsutsugamushiin30) Phan PH, Ngo DT, Ta TA, Kawachi S, Nakajima N,36) Li TC, Yoshizaki S, Kataoka M, Doan YH, Ami Y,Hirata N, Ainai A, Phung TBT, Tran DM, Le HT.

Suzaki Y, Nakamura T, Takeda N, Wakita T.

Successful treatment of pneumonia-induced severe

Determination of Ferret Enteric Coronavirus Genome in

ARDS complicated with DIC in two infants using

Laboratory Ferrets. Emerg Infect Dis. 23:1568-1570.

recombinant human thrombomodulin. Integr Mol Med.

2017

4(3):1-5. 201731) BhatnagarJ,37) Ikeda J, Matsushima A, Ishii W, Goto T, Takahashi K,Rabeneck

DB,MartinesRB,

Nakamichi K, Saijo M, Sekijima Y, Ikeda S. Brain

Reagan-Steiner S, Ermias Y, Estetter LB, Suzuki T,

biopsy is more reliable than the DNA test for JC virus in

Ritter J, Keating MK, Hale G, Gary J, Muehlenbachs A,

cerebrospinal fluid for the diagnosis of progressive

Lambert A, Lanciotti R, Oduyebo T, Meaney-Delman D,multifocal leukoencephalopathy. Internal Medicine.

Bolaños F, Saad EA, Shieh WJ, Zaki SR. Zika Virus

56(10):1231-1234. 2017

RNA Replication and Persistence in Brain and Placental
Tissue. Emerg Infect Dis. 23(3):405-414. 201732) Takahata T, Takeda E, Tobiume M, Tokunaga K,
Yokoyama M, Huang Y-L, Hasegawa A, Shioda T,Sato H, Kannagi M, Masuda T. Critical Contribution ofTyr15 in the HIV-1 Integrase (IN) in Facilitating IN
Assembly and Nonenzymatic Function through the IN